Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension

Sim, John J., Bhandari, Simran K., Shi, Jiaxiao, Reynolds, Kristi, Calhoun, David A., Kalantar-Zadeh, Kamyar, Jacobsen, Steven J.·2015·Kidney International
DOI 10.1038/ki.2015.142

Cited by (240)

Items 101–200 of 240

  1. The Prevalence of Resistant Hypertension Among Type 2 Diabetic Patients Attending the National Center for Diabetes, Endocrinology, and Genetics
    Abeer Mohammad, Mousa A. Abujbara, Jafar Alasad Alshraideh, Hashem Y Jaddou, Kamel M. Ajlouni · 2017 · Journal of Endocrinology and Metabolism
  2. Healthy lifestyle knowledge and age at hypertension diagnosis: a primary health care based survey in Bangladesh
    Md Monirul Islam, Mohammad Safayet Hossain, Mizanur Rahman, Ryota Nakamura, Motohiro Sato · 2025 · Journal of Human Hypertension
  3. Management of hypertension in chronic kidney disease: current perspectives and therapeutic strategies
    Muath A. Alsalloum, Mohamed A. Albekery, Ibrahim S. Alhomoud · 2025 · Frontiers in Medicine
  4. Nonpharmacological Management of Resistant Hypertension
    Ahmad Sabbahi, Richard S. Severin, Deepika Laddu, James E. Sharman, Ross A Arena, Cemal Ozemek · 2021 · Current Cardiology Reports
  5. Systolic Blood Pressure and Pulse Pressure Are Predictors of Future Cardiovascular Events in Patients with True Resistant Hypertension
    José Mesquita Bastos, Lisa Ferraz, Flávio G. Pereira, Susana Lopes · 2023 · Diagnostics
  6. Chronic Kidney Disease
    Silvio Borrelli, Luca De Nicola, Giuseppe Conte, Roberto Minutolo · 2018 · Updates in hypertension and cardiovascular protection
  7. Resistant hypertension
    Fang‐Fei Wei, Zhen‐Yu Zhang, Qi‐Fang Huang, Wen‐Yi Yang, Jan A. Staessen · 2018 · Kardiologia Polska
  8. Associated factors and hemodynamic characteristics of resistant hypertension in the elderly
    Hui Geng, Xiahuan Chen, Wenyi Liang, Meilin Liu · 2023 · Journal of Clinical Hypertension
  9. Real-World Impact of Blood Pressure Control in Patients With Apparent Treatment-Resistant or Difficult-to-Control Hypertension and Stages 3 and 4 Chronic Kidney Disease
    George L. Bakris, Cindy Chen, Alicia K. Campbell, Veronica Ashton, Lloyd Peter Haskell, Mukul Singhal · 2024 · American Journal of Hypertension
  10. Quadruple vs triple therapy for resistant hypertension: the QUADRO trial
    Stefano Taddei, Krzysztof Narkiewicz, Stéphanie Bricout-Hennel, Parvoleta Petrova, Cécile Batailler, Roland G Asmar · 2026 · European Heart Journal
  11. Hyperaldosteronism Screening and Findings From a Large Diverse Population With Resistant Hypertension Within an Integrated Health System
    Victor Kim, Jiaxiao M. Shi, Jaejin An, Simran K. Bhandari, Jeffrey W. Brettler, Michael H. Kanter, John J. Sim · 2023 · The Permanente Journal
  12. Office blood pressure threshold of 130/80 mmHg better predicts uncontrolled out‐of‐office blood pressure in apparent treatment‐resistant hypertension
    Chan Joo Lee, Jeongha Ha, Jang‐Young Kim, In‐Cheol Kim, Sung Kee Ryu, Moo‐Yong Rhee, Ju‐Hee Lee, Jung‐Hee Lee, Hae‐Young Lee, Sang‐Hyun Ihm et al. · 2020 · Journal of Clinical Hypertension
  13. Revisiting resistant hypertension in kidney disease
    Shweta Bansal · 2024 · Current Opinion in Nephrology & Hypertension
  14. GWAS and Replication Analysis of Apparent Treatment-Resistant Hypertension
    Joseph E. Ebinger, Anni Kauko, Felix C. Vaura, Paul Hage, Johan Sundström, FinnGen, Sandy Y. Joung, Susan C. Cheng, Teemu Niiranen · 2025 · Hypertension
  15. Serum Metabolomics and Proteomics to Study the Antihypertensive Effect of Protein Extracts from Tenebrio molitor
    Roberto Stella, Caterina Peggion, Caterina Bergantin, Giancarlo Biancotto, Maria Frosini, Elena Dreassi, Paola Marcolongo, Anna Maria Aloisi, Federica Pessina · 2022 · Nutrients
  16. Apparent Treatment-Resistant Hypertension Among Stroke Survivors: A Transcontinental Study Assessing Impact of Race and Geography
    Fred Stephen Sarfo, Esther B. Olasoji, Grant P Banfill, Bruce I Ovbiagele, Alexis Netis Simpkins · 2022 · American Journal of Hypertension
  17. Resistant Hypertension
    Robert M. Carey · 2015 · Hypertension
  18. ATP2B1 gene polymorphisms associated with resistant hypertension in the Japanese population
    Yusuke Kobayashi, Keisuke Yatsu, Aiko Haruna, Rina Kawano, Moe Ozawa, Tatsuya Haze, Shiro Komiya, Shota Suzuki, Yuki Ohki, Akira Fujiwara et al. · 2024 · Journal of Clinical Hypertension
  19. Aortic blood pressure and arterial stiffness in patients with controlled resistant and non‐resistant hypertension
    Anping Cai, Mohammed Siddiqui, Eric K. Judd, Suzanne Oparil, David A. Calhoun · 2020 · Journal of Clinical Hypertension
  20. Long-term risk for end-stage kidney disease and death in a large population-based cohort
    Emanuel Zitt, Constanze Pscheidt, Hans Concin, Reinhard Kramar, Raphael Simon Peter, Jan Beyersmann, Karl Lhotta, Gabriele Nagel · 2018 · Scientific Reports
  21. New Molecules for Treating Resistant Hypertension: a Clinical Perspective
    Omar Azzam, Márcio Galindo Kiuchi, Jan K. Ho, Vance Bruce Matthews, Leslie Marisol Lugo‐Gavidia, Janis Marc Nolde, Revathy Carnagarin, Markus Peter Schlaich · 2019 · Current Hypertension Reports
  22. Persistent Resistant Hypertension Has Worse Renal Outcomes in Chronic Kidney Disease than that Resolved in Two Years: Results from the KNOW-CKD Study
    Su Hyun Song, Young Jin Kim, Hong Sang Choi, Chang Seong Kim, Eun Hui Bae, Curie Ahn, Kook‐Hwan Oh, Sue-Kyung Park, Kyu‐Beck Lee, Su Ah Sung et al. · 2021 · Journal of Clinical Medicine
  23. Prevalence, phenotypic characteristics and prognostic role of apparent treatment resistant hypertension in the German Chronic Kidney Disease (GCKD) study
    Johanna Mielke, Holger Trucks-Jansen, Claudia Schurmann, Fruzsina Kotsis, Anna Köttgen, Markus Peter Schneider, Kai‐Uwe Eckardt, GCKD Investigators, Fruzsina Kotsis, Anna Köttgen et al. · 2022 · Journal of Human Hypertension
  24. Characterizing apparent treatment resistant hypertension in the United States: insights from the All of Us Research Program
    Mona Alshahawey, Eissa A. Jafari, Steven M. Smith, Caitrin W. McDonough · 2024 · Journal of the American Medical Informatics Association
  25. Prevalence, Risk Factors and Cardiovascular Comorbidities of Resistant Hypertension among Treated Hypertensives in a Nigerian Population
    Olugbenga Olusola Abiodun, Tina Anya, Janefrances Chima Chukwu, Victor Adekanmbi · 2024 · Global Heart
  26. Efficacy and Safety of Baxdrostat in Resistant Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Ashish Wadhwani, Sameer Uttamaro Khasbage, Sumedha Rajendra Zade, Madhusudan P Singh, Yogendra Narayanrao Keche, Priyanka M Ahire · 2026 · Cureus
  27. Application of myocardial work in predicting adverse events among patients with resistant hypertension
    Limin Luo, Yongshi Wang, Huiping Hou, Qiang Liu, Zehan Xie, Qiaoyan Wu, Xianhong Shu · 2023 · Journal of Cardiothoracic Surgery
  28. Recent developments in the management of resistant hypertension: focus on endothelin receptor antagonists
    Sayeh Heidari Nejad, Omar Azzam, Markus Peter Schlaich · 2024 · Future Cardiology
  29. Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program
    Elvis A. Akwo, Cassianne Robinson‐Cohen, Cecilia P. Chung, Shailja C. Shah, Nancy Jeanne Brown, Talat Alp Ikizler, Otis D. Wilson, Bryce X. Rowan, Megan M. Shuey, Edward D. Siew et al. · 2021 · Hypertension
  30. Turkish Society of Cardiology Consensus Paper on Evaluation and Treatment of Resistant Hypertension
    Asife Şahinarslan · 2020 · The Anatolian Journal of Cardiology
  31. Bariatric Surgery for Resistant Hypertension: Working in Progress!
    Carlos Aurélio Schiavon, Andrea Pio-Abreu, Luciano F. Drager · 2020 · Current Hypertension Reports
  32. Risk of fatal and nonfatal coronary heart disease and stroke events among adult patients with hypertension: basic Markov model inputs for evaluating cost-effectiveness of hypertension treatment: systematic review of cohort studies
    Mende Mensa Sorato, Majid Davari, Abbas Kebriaeezadeh, Nizal Sarrafzadegan, Tamiru Shibru, Behzad Fatemi · 2021 · Journal of Pharmaceutical Health Services Research
  33. Variation of Ultrasonic Renal Volume between Hypertensive and Non-Hypertensive Individuals in Relation to Body Size Parameters
    Mesfin Zewdu, Mesfin Zewdu, Elias Kadir, Melkamu Berhane, Tilehun Alemayehu · 2021 · Ethiopian Journal of Health Sciences
  34. BP Targets in CKD, Mortality, and SPRINT: What Have We Learned?
    Stephen C. Textor, Gary L. Schwartz · 2017 · Journal of the American Society of Nephrology
  35. Resistant hypertension: impact and evolving treatment options
    Lilach O. Lerman, Stephen C. Textor · 2015 · Nature Reviews Nephrology
  36. Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?
    Hamish C. G. Prosser, Cynthia Gregory, Dagmara Hering, Graham S. Hillis, Greg J. Perry, Johan B. Rosman, Carl Johann Schultz, Mark Thomas, Gerald Francis Watts, Markus Peter Schlaich · 2017 · Current Hypertension Reports
  37. Gender violence in armed conflicts
    dir. Vitor Rodrigues Viana · 2013 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  38. Contemporary Strategies to Manage High Blood Pressure in Patients with Coexistent Resistant Hypertension and Heart Failure With Reduced Ejection Fraction
    Katherine Lang, Erik H. Van Iterson, Luke Joseph Laffin · 2020 · Cardiology and Therapy
  39. Renal denervation in resistant hypertension treatment
    Andrey Yu. Orekhov, Yersyn Sabitov, Ludmila K. KARAZHANOVA · 2022 · Bratislavské lekárske listy/Bratislava medical journal
  40. Nocturnal nasal congestion is associated with uncontrolled blood pressure in patients with hypertension comorbid obstructive sleep apnea
    Yaxin Guo, Hao Wu, Yongxiang Wei · 2022 · European Archives of Oto-Rhino-Laryngology
  41. Uncontrolled and resistant arterial hypertension: prevalence, methods of modification of therapy
    Юдин Иван Григорьевич, Victor V. Fomin · 2023 · Systemic Hypertension
  42. Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension
    Faris Matanes, Mohammed Siddiqui, Alejandro Velasco, Oleg F. Sharifov, Eric Kreps, Tanja Dudenbostel, Eric K. Judd, Bin Zhang, Steven G. Lloyd, Suzanne Oparil et al. · 2023 · Journal of Clinical Hypertension
  43. Predictive Factors of Apparent Treatment Resistant Hypertension Among Patients With Hypertension Identified Using Electronic Health Records
    Shanshan Lin, Yea‐Jen Hsu, Ji Soo Kim, John W. Jackson, Jodi B Segal · 2024 · Journal of General Internal Medicine
  44. Joint Analysis of Multiple Omics to Describe the Biological Characteristics of Resistant Hypertension
    Shanshan Wang, Yuanlong Hu, Yuqi Wang, Yueyue Song, Dan Liang, Jiufeng Yin, 李运伦, Wenqing Yang, Dan Zhang · 2024 · Journal of Clinical Hypertension
  45. Aprocitentan: a new horizon in the treatment of hypertension
    Eviatar Fields, Ernesto L. Schiffrin · 2025 · Expert Opinion on Pharmacotherapy
  46. Incidence and prognosis of apparent-treatment resistant hypertension: a multi-state analysis using real world evidence
    Htun Teza, Thunyarat Anothaisintawee, Thosaphol Limpijankit, Amarit Tansawet, Suparee Wisawapipat Boonmanunt, Anuchate Pattanateepapon, Gareth J. McKay, John Attia, Ammarin Thakkinstian · 2026 · Clinical Hypertension
  47. Resistant Hypertension Variants Link to Hyperaldosteronism and Potassium Levels
    Vinicius Tragante, Patrick Sulem, Guðmar Þorleifsson, Michael L. Frigge, Joseph G. Arthur, Folkert Wouter Asselbergs, Karina Banasik, Søren Brunak, Alex Hørby Christensen, Dana C. Crawford et al. · 2026 · Hypertension
  48. Antihypertensive therapy and medication adherence in patients with uncontrolled arterial hypertension
    Tatiana D. Solntseva, Сивакова Ольга Анатольевна, Аксенова Анна Владимировна, I. E. Chazova · 2023 · Eurasian heart journal
  49. Resistant Hypertension and Related Outcomes in a Cohort of Patients with Cardiorenal Multimorbidity Hospitalized in an Internal Medicine Ward
    Antonietta Gigante, Rosario Cianci, Claudia Brigato, Michele Melena, Erika Acquaviva, Ludovica Toccini, Chiara Pellicano, Edoardo Rosato, Maurizio Muscaritoli · 2023 · High Blood Pressure & Cardiovascular Prevention
  50. Options for patients with out-of-control blood pressure: after all avenues have been exhausted
    Weiwei Zeng, Brian Tomlinson · 2024 · Expert Review of Cardiovascular Therapy
  51. Resistant hypertension: focus on vascular lesions
    Литвинова Марина Сергеевна, Л. А. Хаишева, Sergey Vladimirovich Shlyk · 2020 · South Russian Journal of Therapeutic Practice
  52. Hipertensión arterial refractaria al tratamiento. Definiciones y manejo actualizado
    Adriana Estefanía Reyes Espinoza, Andrés Santiago Bueno Castro · 2023 · LATAM Revista Latinoamericana de Ciencias Sociales y Humanidades
  53. Hypertonie-Update: Was ist neu?
    Walter Zidek · 2016 · MMW - Fortschritte der Medizin
  54. Apparent Treatment-Resistant Hypertension in the First Year Associated With Cardiovascular Mortality in Peritoneal Dialysis Patients
    Qingyao Zhu, Zhihao Huo, Fang Zeng, Nirong Gong, Peiyi Ye, Jianyi Pan, Yaozhong Kong, Xianrui Dou, Di Wang, Shuting Huang et al. · 2024 · American Journal of Hypertension
  55. Obesity, African American Race, Chronic Kidney Disease, and Resistant Hypertension
    Eric K. Judd, David A. Calhoun · 2015 · Hypertension
  56. Cardiovascular Risk Factors in Middle-Aged Lithuanian Men: A Comparative Study of an Apparently Resistant Hypertension Group
    Vaida Šileikienė, Vilma Dzenkeviciute, Alma Čypienė, Martynas Bublys, Roma Puronaitė, Jolita Badarienė, Aleksandras Laucevičius, Eglė Butkevičiūtė, Egidija Rinkūnienė · 2025 · Biomedicines
  57. Recognize, Monitor, Treat
    Lilit Vardanyan, Brenda Martinez-Puente, Milan Acosta, Kevin Khoa Trinh, Surabhi Madhwal Atreja · 2025 · JACC Case Reports
  58. Pharmacogenomics-Guided Precision Therapy for Chronic Kidney Disease with Resistant Hypertension: A Prospective Cohort Study
    Xiaowen Ha, Xiyuan Gao, Wei Teng, Jiali Zhang, Zuolamu Maimaiti, Dilina Yalikun, ShuFen Yang, Lu Bai, Takexi Caoke, Hong Xiang Jiang · 2025 · Kidney & Blood Pressure Research
  59. The Role of Mineralocorticoid Receptors in the Treatment of Primary Hypertension
    Jehan Zahid Bahrainwala, Vivek Bhalla · 2026 · Current Hypertension Reports
  60. Assessment of adherence to treatment in patients with resistant arterial hypertension according to Russian-language literature. A systematic review
    Sergey Yu. Yarovoy, Galina V. Shchelkova, Диневич Екатерина Олеговна, Irina E. Chazova, С. А. Бойцов · 2025 · Russian Cardiology Bulletin
  61. The Role of β-Blockers in the Evolving Treatment Landscape of Resistant Hypertension
    Stefano Masi, Atul Pathak, Rosa María Bruno, Sofie Brouwers, Krzysztof Narkiewicz, Stefano Taddei, Konstantinos P Tsioufis, Reinhold Hugo Kreutz · 2026 · Drugs
  62. A Systematic Literature Review of Health Economic Modelling Approaches Used to Evaluate Treatment Resistant and Uncontrolled Hypertension: A Critical Appraisal and Considerations for the Design of Future Model Analyses
    Matthew Franklin, James Fotheringham, Rod S. Taylor, Philip A. Powell, Lise Retat, Jieling Chen, Juan José García Sánchez, Amy Gamble, Patrice Carter · 2026 · PharmacoEconomics
  63. Characterizing Alzheimer’s Disease and Related Dementia in a Hypertension Population Within the State of Florida Using Electronic Health Record–Based Data
    Eissa A. Jafari, Mona Alshahawey, Muhammad Arfan Zaman, Steven M. Smith, Yan Gong, Glenn E. Smith, Caitrin W. McDonough · 2025 · Clinical Pharmacology & Therapeutics
  64. Secondary causes and renal outcomes in apparently resistant hypertension: a retrospective cohort study
    Tomáš Kvapil, Eva Kociánová, Zdeněk Ramík, Jan Olšr, Martin Rada, Jakub Flašík, Martin Modrák, Libor Jelínek, Jan Mizera, Jan Václavík · 2026 · Blood Pressure
  65. Comparison of the Efficacy of Different Treatment Regimens for Resistant Hypertension: A Systematic Review and Network Meta‐Analysis
    Yao Xiao, Kun Feng, X P Chen, Yong Peng, Kai Liu · 2026 · Journal of Evidence-Based Medicine
  66. Resistant Hypertension and Cardiorenovascular Risk
    Ingrid Prkačin, Petra Vrdoljak, Gordana Cavrić, Damir Važanić, Petra Pervan, Višnja Nesek Adam · 2017 · BANTAO Journal
  67. Effects of different ablation points of renal denervation on the efficacy of resistant hypertension
    Hua Zhang, Lingyan Li, Rong-Xue Xiao, Ting-Chuan Zhang, Zongjun Liu, Junqing Gao · 2020 · PeerJ
  68. Prevalence and clinical outcomes of patients with apparent treatment‐resistant hypertension enrolled in Phase 2 cardiac rehabilitation
    Luke Joseph Laffin, Asad Khan, Katherine Lang, Erik H. Van Iterson · 2020 · Journal of Clinical Hypertension
  69. Understanding resistant hypertension
    Alexandra Bachinsky, Erin Leah Jones, Tiffany Thompson, Sondra M. DePalma, Joyce S. Nicholas, Eric Schmidt · 2021 · JAAPA
  70. A prospective randomized comparative study of Glidescope versus Macintosh laryngoscope in adult hypertensive patients
    Salwa Mohamed Sabry Hayes, Mahmoud M. Othman, Ahmed M. A. Bobo, Ibrahim Abdelbaser · 2022 · Egyptian Journal of Anaesthesia
  71. Value of Routine Screening for Hypertension in Childhood
    Michael G. Semanik, Joseph T. Flynn · 2018 · Springer eBooks
  72. The enigma of resistant hypertension: from lifestyle changes and pharmacological treatment to renal denervation
    Massimo Volpe, Giovanna Gallo · 2022 · European Heart Journal Supplements
  73. Bilateral Nephrectomy for Resistant Hypertension and Secondary Aldosteronism in a Hemodialysis Patient: A Case Report
    Kota Nishihama, Chisa Inoue, Kohei Nishikawa, Yuko Okano, Atsuro Takeshita, Mei Uemura, Taro Yasuma, Toshinari Suzuki, Ryuji Okamoto, Corina N. D’Alessandro‐Gabazza et al. · 2023 · Internal Medicine
  74. Unexpected improvement of resistant hypertension in older adults: A red flag sign
    Ami Schattner · 2024 · Geriatrics and gerontology international/Geriatrics & gerontology international
  75. Prevalence of atherosclerotic cardiovascular diseases and risk factors among pre-dialysis chronic kidney disease patients at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia: A cross-sectional study
    Yidnekachew Asrat, Sintayehu Abebe Gebru, Addisu Melkie Ejigu, Dessalew Mekonnen, Tesfamariam Aklilu, Senbeta Guteta Abdissa · 2025 · Heart Vessels and Transplantation
  76. Prognosis of patients with apparent treatment-resistant hypertension—a feasibility study
    Peter Hayes, Hannah Kielty, Monica Casey, Liam George Glynn, Gerard J. Molloy, Hannah Durand, John Newell, Andrew William Murphy · 2018 · Pilot and Feasibility Studies
  77. Cardiovascular Outcomes and Potential Long-term Benefits of Renal Denervation in Patients with Resistant Hypertension
    Marija Magdalena Jakopović, Anja Ivošević, Marija Stanković, Ingrid Prkačin · 2018 · Cardiologia Croatica
  78. Novel approaches to treat resistant hypertension
    Aleksandra Cherneva, Ivo Spasov Petrov · 2020 · Bulgarian Cardiology
  79. Role of spironolactone in patients with resistant hypertension
    Geeta Sheth, KAVITA JOSHI · 2021 · Heart India
  80. Resistant Hypertension
    I. Prkačin, D. Rudan, Tomo Svaguša, Matija Bakoš, Z. Šalek · 2018 · Blood Pressure
  81. POSICIONAMENTO BRASILEIRO SOBRE HIPERTENSÃO ARTERIAL RESISTENTE – 2020
    Faculdade Estadual de Medicina de São José do Rio Preto, São José do Rio Preto, SP – Brasil, Juan Carlos Yugar‐Toledo, Heitor Moreno, Miguel Gus, Guido Bernardo Aranha Rosito, Luíz Cesar Nazário Scala, Elizabeth Silaid Muxfeldt, Alexandre Alessi, Andréa Araújo Brandão, Osni Moreira Filho et al. · 2020 · Revista Brasileira de Hipertensão
  82. Value of Routine Screening for Hypertension in Childhood
    Joseph T. Flynn · 2023 · Springer eBooks
  83. Testing for Secondary Hypertension and Difficult to Control Patients
    Omar Azzam, Márcio Galindo Kiuchi, Revathy Carnagarin, Markus Peter Schlaich · 2023 · Springer eBooks
  84. Treating Hypertension in Diabetic Patients With Advanced Chronic Kidney Disease: What Should We Have in Mind?
    Panagiotis I. Georgianos, Elias V. Balaskas, Pantelis E Zebekakis · 2016 · Journal of Clinical Hypertension
  85. Associação da Apneia Obstrutiva do Sono com a Lesão de Órgãos-Alvo: Comparação entre Hipertensos não Resistentes e Resistentes
    Mayara Longui Cabrini · 2021
  86. Faculty Opinions recommendation of Resistant hypertension: detection, evaluation, and management: A scientific statement from the american heart association.
    Athanasios John Manolis · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  87. Targeted approaches to diagnose and treat resistant hypertension in Asia
    Keisuke Narita · 2024 · Hypertension Research
  88. Total Management of CKD
    Yukinao Sakai, Shichi Tsuruoka · 2016 · Nihon Ika Daigaku Igakkai Zasshi
  89. Value of Routine Screening for Hypertension in Childhood
    Michael G. Semanik, Joseph T. Flynn · 2016 · Springer eBooks
  90. Resistant Hypertension and Outcomes in Patients with and Without Chronic Kidney Disease
    Aghogho Odudu, Maharajan Raman, Philip A. Kalra · 2017 · Springer eBooks
  91. The Importance of Ambulatory and Home Monitoring Blood Pressure in Resistant Hypertension Associated with Chronic Kidney Disease
    Silvio Borrelli, Luca De Nicola, Giuseppe Conte, Roberto Minutolo · 2017 · Springer eBooks
  92. Clinical and Physiological Aspects of Salt Sensitive Hypertension
    Martin J. Wolley · 2017 · The University of Queensland
  93. Role of Physical Activity, Exercise, and Cardiorespiratory Fitness in the Management of Resistant Hypertension
    Puneet Narayan, Anubhav Kumar · 2019 · Springer eBooks
  94. Analysis of Prevalence of Hypertension and Diet Structure in Mongolian Population in Hohhot
    建冬 韩 · 2018 · Medical Diagnosis
  95. Estudo de polimorfismos genéticos em portadores de hipertensão arterial resistente controlada e não controlada
    Luiz Henrique da Silveira Cavalcanti · 2020
  96. Midterm complications of ROX arteriovenous coupler device, managed by targeted endovascular repair: a case report
    Sherif Sultan, Mohamed Kamal Elbashir Mustafa, Nora Barrett, Niamh Hynes · 2020 · European Heart Journal - Case Reports
  97. Therapieresistente Hypertonie: 40 Prozent der Nierenpatienten sind betroffen
    Horst Gross · 2020 · CardioVasc
  98. ESPIRONOLACTONA OU CLONIDINA COMO QUARTO FÁRMACO NA HIPERTENSÃO RESISTENTE?
    Daniel S.S. Mello, Julia S. Gomes, Audes D. M. Feitosa, Pronto Socorro Cardiológico de Pernambuco (PROCAPE), Recife, PE, Brasil, José R. Matos‐Souza, Wilson Nadruz · 2020 · Revista Brasileira de Hipertensão
  99. HIPERTENSÃO RESISTENTE: ANÁLISE DOS ESTUDOS PATHWAY 2 E 3
    Fernando Focaccia Póvoa, Dilma Do S. M. De Souza, Rui Póvoa · 2021 · Revista Brasileira de Hipertensão
  100. The Relationship Between Myocardial Performance Index and Renal Resistive Index in Resistant Hypertension
    Cafer Panç, İsmail Gürbak, Arda Güler, Çağdaş Topel, Mehmet Ertürk · 2021 · Hamidiye Medical Journal